These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13633510)

  • 21. [Determination of uric acid in blood; effect of sunlight on preservation of standard uric acid solution].
    VINCENT D; MIGNON M
    Ann Biol Clin (Paris); 1957; 15(7-9):510-3. PubMed ID: 13458903
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of uric acid in cardiovascular diseases].
    Wdowczyk M; Bednarska-Chabowska D; Adamiec R
    Przegl Lek; 2003; 60(11):755-7. PubMed ID: 15058051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behavior of the blood copper curve after intravenous loading with copper gluconate in rheumatic diseases].
    CAIOZZO A; SAVAGNONE E
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):672-5. PubMed ID: 13105999
    [No Abstract]   [Full Text] [Related]  

  • 24. Genome scan for determinants of serum uric acid variability.
    Nath SD; Voruganti VS; Arar NH; Thameem F; Lopez-Alvarenga JC; Bauer R; Blangero J; MacCluer JW; Comuzzie AG; Abboud HE
    J Am Soc Nephrol; 2007 Dec; 18(12):3156-63. PubMed ID: 17978310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does coffee drinking influence serum uric acid concentration?].
    Olak-Białoń B; Marcisz C; Jonderko G; Olak Z; Szymszal J; Orzeł A
    Wiad Lek; 2004; 57 Suppl 1():233-7. PubMed ID: 15884246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function.
    Afsar B; Elsurer R; Ozdemir FN; Sezer S
    J Nephrol; 2008; 21(3):406-11. PubMed ID: 18587730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sectional blood oxymetry in rheumatic disease].
    SCALABRINO R; PASQUARIELLO G
    Minerva Med; 1955 Feb; 46(14):445-6. PubMed ID: 14355908
    [No Abstract]   [Full Text] [Related]  

  • 29. A preliminary investigation of the association between serum uric acid and impaired renal function.
    Chen YC; Su CT; Wang ST; Lee HD; Lin SY
    Chang Gung Med J; 2009; 32(1):66-71. PubMed ID: 19292941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of tobacco smoking during pregnancy on concentration of uric acid in matched-maternal cord pairs].
    Chełchowska M; Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Leibschang J
    Przegl Lek; 2007; 64(10):667-70. PubMed ID: 18409282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholinesterase power of the serum in rheumatic disease].
    SANTENOISE D; FONTAN M; GAULIER G; WACHEMACKER R; LEBEURRE J
    Rev Pathol Gen Physiol Clin; 1954 Jul; 54(660):980-4. PubMed ID: 13204984
    [No Abstract]   [Full Text] [Related]  

  • 35. [C-reactive protein in rheumatic diseases].
    OKA M; KYTILA J
    Duodecim; 1957; 73(7-8):396-407. PubMed ID: 13473708
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative examinations of the level of plasma tryptophan & of other clinical tests in the course of treatment of lingering rheumatic diseases].
    SOKOLOWSKI A; GABRYELSKI W
    Postep Reumatol; 1957; 3():49-56. PubMed ID: 13542305
    [No Abstract]   [Full Text] [Related]  

  • 37. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protein levels & fractions in rheumatic diseases of the nervous system].
    BOBROVSKAIA GD; KUCHEROVA LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(3):318-24. PubMed ID: 13605151
    [No Abstract]   [Full Text] [Related]  

  • 39. [Data furnished by paper electrophoresis in rheumatic diseases].
    LAYANI F; ASCHKENASY A; BENGUI A
    Rev Rhum Mal Osteoartic; 1957 Nov; 24(11):711-39. PubMed ID: 13528479
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of C-reactive protein in rheumatic diseases].
    ARMAS-CRUZ R; ARMIJO G; DEL RIO R; GONZALEZ F; VICUNA JP; LOBOPARGA G
    Rev Med Chil; 1957 Jun; 85(6):329-33. PubMed ID: 13494920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.